home / stock / aplt / aplt news

APLT News and Press, Applied Therapeutics Inc. From 06/15/20

Stock Information
Company Name: Applied Therapeutics Inc.
Stock Symbol: APLT
Market: NYSE
Website: appliedtherapeutics.com
Menu
APLT APLT Quote APLT Short APLT News APLT Articles APLT Message Board
Get APLT Alerts

News, Short Squeeze, Breakout and More Instantly...
APLT - Applied Therapeutics reports additional 40mg/kg data from adult galactosemia study

Applied Therapeutics (NASDAQ: APLT ) announces additional supportive biomarker efficacy and safety data for AT-007 in Galactosemia at 40 mg/kg. More news on: Applied Therapeutics, Inc., Healthcare stocks news, Read more ...

APLT - Applied Therapeutics Announces Start of AT-007 Pediatric Galactosemia Study; Releases Additional 40mg/kg Data from Adult Galactosemia Study

AT-007 pediatric Galactosemia study (ACTION-Galactosemia Kids) initiated Additional 40mg/kg adult cohort demonstrates incremental efficacy; data reinforces AT-007 favorable safety and efficacy profile NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasd...

APLT - Mixed shelf roundup - healthcare

The following healthcare companies have filed prospectuses for mixed shelf offerings: More news on: Genprex, Inc., Syros Pharmaceuticals, Inc., ChromaDex Corporation, Healthcare stocks news, , Read more ...

APLT - Applied Therapeutics to Present Data on AT-001 for the Treatment of Diabetic Cardiomyopathy at 2020 American Diabetes Association Virtual Scientific Sessions

NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that three abstract...
APLT - Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

NEW YORK, June 03, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will p...

APLT - Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development

NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today the appointment...

APLT - Applied Therapeutics to Present at the UBS Global Healthcare Conference

NEW YORK, May 12, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will ...
APLT - Applied Therapeutics EPS beats by $0.16

Applied Therapeutics (NASDAQ: APLT ): Q1 GAAP EPS of -$0.59 beats by $0.16 . More news on: Applied Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

APLT - Applied Therapeutics Reports First Quarter 2020 Financial Results

NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for...

APLT - Applied Therapeutics (APLT) Galactosemia Educational Symposium - Slideshow

The following slide deck was published by Applied Therapeutics, Inc. in conjunction with this Read more ...

Previous 10 Next 10